Search Results - "Pedrana, A."

Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia by Schroeder, Sophia E, Wilkinson, A L, O'Keefe, D, Bourne, A, Doyle, J S, Hellard, M, Dietze, P, Pedrana, A

“…Gay, bisexual and other men who have sex with men (GBMSM) are overrepresented in cohorts of people who inject drugs. GBMSM's substance use is usually explored…”
Get full text

Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond by Hellard, M., Scott, N., Sacks-Davis, R., Pedrana, A.

Get full text

Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review by Shen, C., Dawe, J., Traeger, M.W., Sacks-Davis, R., Pedrana, A.E., Doyle, J.S., Hellard, M.E., Stoové, M

“…•Evidence for effectiveness of incentives to promote HCV care outcomes.•No randomised controlled trial assessed effectiveness of incentives for HCV…”
Get full text

Constructing a ‘target population’: A critical analysis of public health discourse on substance use among gay and bisexual men, 2000–2020 by Schroeder, SE, Bourne, A, Doyle, JS, Hellard, ME, Stoové, M, Pedrana, A

“…BACKGROUNDGay and bisexual men (GBM) have higher substance use prevalences than general population samples - often attributed to stigmatisation of sexual…”
Get full text

Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol by Marukutira, Tafireyi, Moore, Karen P, Hellard, Margaret, Richmond, Jacqui, Turner, Kate, Pedrana, A E, Melody, Shannon, Johnston, Fay H, Owen, Louise, Van Den Boom, Wijnand, Scott, N, Thompson, Alexander, Iser, David, Spelman, Tim, Veitch, Mark, Stoové, Mark A, Doyle, Joseph

“…IntroductionBy subsidising access to direct acting antivirals (DAAs) for all people living with hepatitis C (HCV) in 2016, Australia is positioned to eliminate…”
Get full text

Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department by Hutton, J., Doyle, J., Zordan, R., Weiland, T., Cocco, A., Howell, J., Iser, S., Snell, J., Fry, S., New, K., Sloane, R., Jarman, M., Phan, D., Tran, S., Pedrana, A., Williams, B., Johnson, J., Glasgow, S., Thompson, A.

“…In Australia, Hepatitis C Virus (HCV) treatment is declining, despite broad access to direct-acting antiviral medication. People who inject drugs are…”
Get full text

Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility by MacIsaac, Michael B, Whitton, Bradley, Anderson, Jenine, Cogger, Shelley, Vella-Horne, Dylan, Penn, Matthew, Weeks, Anthony, Elmore, Kasey, Pemberton, David, Winter, Rebecca J, Papaluca, Timothy, Howell, Jessica, Hellard, Margaret, Stoové, Mark, Wilson, David, Pedrana, Alisa, Doyle, Joseph S, Clark, Nicolas, Holmes, Jacinta A, Thompson, Alexander J

“…To achieve hepatitis C virus (HCV) elimination targets, simplified care engaging people who inject drugs is required. We evaluated whether fingerstick HCV RNA…”
Get full text

Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study) by O’Keefe, Daniel, Gunn, J, Ryan, Kathleen, Djordjevic, Filip, Kerr, Phoebe, Gold, Judy, Elsum, Imogen, Layton, Chloe, Chan, Kico, Dietze, Paul, Higgs, Peter, Doyle, Joseph, Stoové, Mark A, Hellard, Margaret, Pedrana, A E

“…IntroductionThe advent of direct acting antiviral therapy for hepatitis C virus (HCV) means the elimination of HCV is possible but requires sustained effort to…”
Get full text

Reaching hepatitis C virus elimination targets in Australia requires use of complementary cost-effective interventions along the care cascade by Scott, N, Doyle, J, Wade, A, Wilson, D.P, Howell, J, Pedrana, A, Thompson, A, Hellard, M

Get full text

A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol by Callander, D, Stoové, M, Carr, A, Hoy, J F, Petoumenos, K, Hellard, M, Elliot, J, Templeton, D J, Liaw, S, Wilson, D P, Grulich, A, Cooper, D A, Pedrana, A, Donovan, B, McMahon, J, Prestage, G, Holt, M, Fairley, C K, McKellar-Stewart, N, Ruth, S, Asselin, J, Keen, P, Cooper, C, Allan, B, Kaldor, J M, Guy, R

“…Australia has increased coverage of antiretroviral treatment (ART) over the past decade, reaching 73% uptake in 2014. While ART reduces AIDS-related deaths,…”
Get full text

O15 Recommendations for hepatitis C virus testing among people who inject drugs in Australia by N. Scott, J. Doyle, J. Howell, A. Pedrana, B. Williams, A. Thompson, M. Hellard

Get full text

P59 Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade by N. Scott, J. Doyle, D. Wilson, A. Wade, J. Howell, A. Pedrana, A. Thompson, M. Hellard

Get full text

O17 Eliminate Hepatitis C Partnership: clinical site scoping by E. Wong, A. Pedrana, B.L. Draper, J. Gold, J. Richmond, M. Stoove, J.S. Doyle, A.J. Thompson, M.E. Hellard

Get full text

P48 Implementing an elimination program for hepatitis C: a partnership approach from Victoria by A. Pedrana, J. Doyle, M. Stoove, J. Richmond, J. Gold, P. Dietze, P. Higgs, N. Scott, J. Howell, E. McBryde, W. Sievert, D. Petrie, P. Vickerman, D. DiGiacomo, M. Eagle, J. Kelsall, A. Thompson, M. Hellard

Get full text

128 HEPATITIS C INFECTION, CLEARANCE AND REINFECTION IN A COHORT OF INJECTING DRUG USERS – A HIGHLY DYNAMIC PROCESS by Hellard, M, Davis, R. Sacks, Spelman, T, Higgs, P, Pedrana, A, Bharadwaj, M, Bowden, S, Drummer, H, Aitken, C

Get full text

Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade by Scott, Nick, Doyle, Joseph S., Wilson, David P., Wade, Amanda, Howell, Jess, Pedrana, Alisa, Thompson, Alexander, Hellard, Margaret E.

“…Modelling suggests that achieving the World Health Organization’s elimination targets for hepatitis C virus (HCV) is possible by scaling up use of…”
Get full text

Heterogeneity in hepatitis C virus treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access by Scott, N., Hainsworth, S., Sacks-Davis, R., Pedrana, A., Doyle, J., Hellard, M.

Get full text

THU-052 - Heterogeneity in hepatitis C virus treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access by Scott, N., Hainsworth, S., Sacks-Davis, R., Pedrana, A., Doyle, J., Hellard, M.

Get full text

Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study by Williams, Bridget, Howell, Jessica, Doyle, Joseph, Thompson, Alexander J., Draper, Bridget, Layton, Chloe, Latham, Ned, Bramwell, Frances, Membrey, Dean, Mcpherson, Maggie, Roney, Janine, Stoové, Mark, Hellard, Margaret E., Pedrana, Alisa

“…Achieving hepatitis C elimination requires novel approaches to engage people at highest risk of infection into care pathways. Point-of-care-tests may help to…”
Get full text

FRI-475 - Reaching hepatitis C virus elimination targets in Australia requires use of complementary cost-effective interventions along the care cascade by Scott, N., Doyle, J., Wade, A., Wilson, D.P., Howell, J., Pedrana, A., Thompson, A., Hellard, M.

Get full text